Abstract:Objective MiRNAs microarray was employed to determine the differential time-specific expression of miRNAs in ventricular myocardium of fetus with ventricular septal defect(VSD) in the different gestational ages(the first trimester and the second trimester).Methods The VSD group was recruited from the fetuses with VSD aborted for pathological factors,and was divided into VSD subgroups:subgroup 1 for the first trimester and subgroup 2 for the second trimester according to the gestational ages.The control group was chosen from the fetuses of inevitable abortion without cardiac malformations,and was divided into the control subgroups in the same way.The fetal ventricular myocardiums were acquired and RNAs were extracted and processed.The Agilent Human 2.0 microarrays containing 723 known miRNAs were applied to get the data about miRNAs expression changes,the data were analyzed by bioinformatics methods:differential miRNAs expression analysis,target gene ontology analysis and pathway-express analysis.Differential expressions of miRNAs microarray were certificated by real-time PCR.Results VSD group and control group had 6 fetuses,respectively,with 3 fetuses in the first trimester and 3 in the second trimester,respectively.①There were 33 differential time-specific expression of miRNAs in the 2 VSD subgroups.Expressions of 19 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.Expressions of 14 miRNAs were up-regulated in subgroup 1 and down-regulated in subgroup 2.②A total of 2 761 target genes were predicted by bioinformatic methods.The most of target genes were directly associated with the key genes of heart development(such as TBX5,GATA4,TBX1,NKX2-5,etc.).③The gene ontology analysis indicated that target genes were mainly related to the cellular process,metabolic process and biological regulation,and accounted for 23.5 %,18.3%,17.7% of the total number of target genes,respectively.④The pathway-express analysis indicated that the WNT signaling pathway played an important role in both VSD subgroups.⑤Four miRNAs(hsa-miR-19a,hsa-let-7e,hsa-miR-134 and hsa-miR-206) were randomly selected and verified by real-time PCR,the results of quantitative PCR were basically consistent with the microarray results.Conclusions The differential time-specific expression of miRNAs may play an important role in the occurrence and development of fetal VSD malformations,but it needs confirmation by study with larger sample size.These predicted target genes were mainly related to cell growth,differentiation and metabolism;partially were directly associated with the key genes of heart development;partially were key factors of the WNT signaling pathway.The occurrence and development of fetal VSD malformations were the joint results of imbalance gene expression which functioned at different levels under the participation of miRNAs.

Inferring novel lncRNA associated with Ventricular septal defect by DNA methylation interaction network

Differential lncRNA/mRNA expression profiling and ceRNA network analyses in amniotic fluid from foetuses with ventricular septal defects

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect

Differential Expression of CircRNAs in Embryonic Heart Tissue Associated with Ventricular Septal Defect

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

The Interaction Analysis of SNP Variants and DNA Methylation Identifies Novel Methylated Pathogenesis Genes in Congenital Heart Diseases

Copy Number Variation-Associated Lncrnas May Contribute to the Etiologies of Congenital Heart Disease

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Integrated genomic analysis identifies novel low-frequency <i>cis</i>-regulatory variant rs2279658 associated with VSD risk in Chinese children

Differential Time-Specific Expression of Mirnas in Ventricular Myocardium of Fetus with Ventricular Septal Defect

Identification of Long Non-coding RNA Candidate Disease Genes Associated with Clinically Reported CNVs in Congenital Heart Disease

Long noncoding RNA SNHG6 contributes to ventricular septal defect formation via negative regulation of miR-101 and activation of Wnt/β-catenin pathway.

Expression Signatures of Long Noncoding RNAs in Left Ventricular Noncompaction

<i>NOTCH1</i> Gene MicroRNA Target Variation and Ventricular Septal Defect Risk

Novel NKX2-5 Mutations Identified in Patients with Congenital Ventricular Septal Defects

NOTCH1 Gene MicroRNA Target Variation and Ventricular Septal Defect Risk.

Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects

Microrna Expression Profiling in Fetal Single Ventricle Malformation Identified by Deep Sequencing.

Identification Of Novel Single-Nucleotide Variants With Potential Of Mediating Malfunction Of Microrna In Congenital Heart Disease

Maternal Circulating Exosomal miRNAs as Non-invasive Biomarkers for the Prediction of Fetal Ventricular Septal Defect